| Not Yet Recruiting | Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases NCT07537959 | Tongji Hospital | N/A |
| Recruiting | A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People Wit NCT07477457 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine NCT06787014 | Insel Gruppe AG, University Hospital Bern | — |
| Recruiting | Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers o NCT06712745 | University of Texas Southwestern Medical Center | EARLY_Phase 1 |
| Not Yet Recruiting | Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast NCT06993506 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Recruiting | A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic C NCT06863272 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Recruiting | Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in NCT07040657 | Dokuz Eylul University | N/A |
| Recruiting | Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in NCT07154563 | Yunnan Cancer Hospital | — |
| Recruiting | Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirP NCT06945978 | Benedito Mauro Rossi | — |
| Not Yet Recruiting | A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Cur NCT06719479 | SUNHO（China）BioPharmaceutical CO., Ltd. | Phase 2 / Phase 3 |
| Recruiting | A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases NCT06567353 | Ruijin Hospital | N/A |
| Withdrawn | SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy NCT06282185 | Canisius-Wilhelmina Hospital | N/A |
| Recruiting | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369 | 7 Hills Pharma, LLC | Phase 1 / Phase 2 |
| Completed | EchoTip AcuCore Post-Market Clinical Study NCT06358001 | Cook Research Incorporated | — |
| Not Yet Recruiting | Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer NCT05810792 | Sahlgrenska University Hospital | Phase 2 |
| Recruiting | Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model NCT06202404 | Fudan University | — |
| Recruiting | Definitive Radiation for High-Risk Spine Metastases NCT06165419 | Stony Brook University | Phase 2 |
| Not Yet Recruiting | Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study NCT06150222 | Erasmus Medical Center | — |
| Recruiting | Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases NCT05789589 | Baptist Health South Florida | Phase 1 / Phase 2 |
| Recruiting | Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer. NCT06700057 | Institut Bergonié | — |
| Recruiting | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer NCT05542407 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Not Yet Recruiting | Role of FDG PET/CT in Patients With Metastasis of Unknown Origin NCT06055764 | Assiut University | — |
| Recruiting | Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study. NCT07400809 | Tata Memorial Hospital | — |
| Completed | Interobserver Variability Desmoplasia NCT06020612 | Maastricht University Medical Center | — |
| Recruiting | Study of PAT in Patients With Solid Tumor Cancers NCT05338658 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer NCT05755347 | UNC Lineberger Comprehensive Cancer Center | — |
| Recruiting | Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer NCT05947695 | Good Samaritan Hospital Medical Center, New York | N/A |
| Recruiting | The Impact of Radiotherapy on Oligometastatic Cancer NCT05933876 | Institut Investigacio Sanitaria Pere Virgili | — |
| Unknown | Collection of Pleural Effusion Fluid NCT05539183 | Universitair Ziekenhuis Brussel | N/A |
| Not Yet Recruiting | Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Comb NCT04845490 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Recruiting | Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis NCT06884839 | Minia University | — |
| Unknown | Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma NCT04683575 | Qianfoshan Hospital | Phase 4 |
| Unknown | Liver Transplantation for Unresectable GIST Liver Metastases NCT04825470 | Hospital Universitario Virgen de la Arrixaca | N/A |
| Unknown | A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 NCT05200273 | Akeso | Phase 1 |
| Recruiting | FAPI PET/CT in Various FAP-Related Disease Patients NCT06688071 | Tianjin Medical University | — |
| Recruiting | Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases NCT06690736 | Tianjin Medical University | N/A |
| Active Not Recruiting | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in T NCT05103358 | Aadi Bioscience, Inc. | Phase 2 |
| Active Not Recruiting | Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer NCT05021237 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery NCT05028400 | Insel Gruppe AG, University Hospital Bern | N/A |
| Unknown | Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carci NCT05845632 | Maastricht University Medical Center | — |
| Unknown | Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer NCT05208372 | First Hospital of China Medical University | — |
| Completed | Cemiplimab for Secondary Angiosarcomas NCT04873375 | Radboud University Medical Center | Phase 2 |
| Unknown | Evaluation of Fast, Same-day Delivery of Palliative Radiotherapy Without a Planning CT (FAST-METS) NCT05288608 | Amsterdam UMC, location VUmc | — |
| Unknown | Genomic Evolution of Metastasis in Gastric Cancer NCT05061082 | University Medical Center Ho Chi Minh City (UMC) | — |
| Unknown | Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas NCT04617457 | University of Cologne | Phase 2 |
| Recruiting | Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast C NCT05095207 | Icahn School of Medicine at Mount Sinai | Phase 1 / Phase 2 |
| Unknown | Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined Wi NCT04808466 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Completed | Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients NCT05002140 | XRad Therapeutics Inc | Phase 1 |
| Not Yet Recruiting | An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy f NCT04890522 | Sun Yat-sen University | Phase 2 / Phase 3 |
| Unknown | T1 Squamous Cell Carcinomas of the Lip NCT05610293 | Maastricht University Medical Center | — |
| Unknown | Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric NCT05095636 | Fudan University | Phase 2 |
| Recruiting | Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer NCT04743102 | Beijing Chao Yang Hospital | N/A |
| Unknown | TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracil NCT04392479 | Hôpital Franco-Britannique-Fondation Cognacq-Jay | Phase 3 |
| Recruiting | Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients NCT06690970 | Tianjin Medical University | — |
| Unknown | 68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer NCT04525612 | First Affiliated Hospital of Fujian Medical University | EARLY_Phase 1 |
| Unknown | 68Ga-FAPI PET/CT in Patients With Various Types of Cancer NCT04499365 | First Affiliated Hospital of Fujian Medical University | EARLY_Phase 1 |
| Unknown | Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE NCT04720768 | Peter MacCallum Cancer Centre, Australia | Phase 1 / Phase 2 |
| Not Yet Recruiting | SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma NCT04351282 | Fudan University | N/A |
| Terminated | Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients NCT04261777 | Saving Patients' Lives Medical B.V. | Phase 3 |
| Unknown | Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Ca NCT04472403 | Sun Yat-sen University | — |
| Recruiting | Comparison of FDG and FAPI in Patients With Various Types of Cancer NCT04416165 | The First Affiliated Hospital of Xiamen University | N/A |
| Unknown | Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC) NCT03909724 | Amsterdam UMC, location VUmc | Phase 2 / Phase 3 |
| Unknown | Percutaneous Vertebroplasty Using Rotary Cutter for Bone Metastases NCT04017728 | Li Min | N/A |
| Terminated | Palliative Radiation Oncology Chief's Clinic NCT03995927 | Wake Forest University Health Sciences | — |
| Terminated | A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic S NCT04009681 | Synthorx, Inc, a Sanofi company | Phase 1 / Phase 2 |
| Completed | Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy NCT03824366 | Washington University School of Medicine | N/A |
| Unknown | Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroi NCT04180007 | Nanjing First Hospital, Nanjing Medical University | Phase 2 |
| Unknown | Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer NCT03913182 | Shanghai Chest Hospital | Phase 2 |
| Unknown | Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma NCT03799744 | Institut Català d'Oncologia | Phase 1 |
| Recruiting | Somatostatin Receptor PET/CT in SSTR-Related Disease Patients NCT06690957 | Tianjin Medical University | — |
| Completed | Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas NCT03783936 | Ashwin Somasundaram | Phase 2 |
| Completed | Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homolo NCT03652493 | Centre Francois Baclesse | Phase 2 |
| Unknown | Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. NCT03644303 | Royal Marsden NHS Foundation Trust | N/A |
| Unknown | A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her NCT03560856 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors NCT03644056 | ImmuneOncia Therapeutics Inc. | Phase 1 |
| Completed | Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer NCT03927287 | Rabin Medical Center | — |
| Completed | Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors NCT03340844 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | N/A |
| Terminated | Kypho-IORT vs. EBRT in Spinal Metastases NCT02773966 | Universitätsmedizin Mannheim | Phase 3 |
| Terminated | Pembrolizumab + Idelalisib for Lung Cancer Study NCT03257722 | Asha Nayak | Phase 1 / Phase 2 |
| Completed | Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel NCT03295565 | The Netherlands Cancer Institute | Phase 2 / Phase 3 |
| Unknown | Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma) NCT03230201 | Peking University First Hospital | N/A |
| Unknown | Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC) NCT02942238 | Ruijin Hospital | N/A |
| Completed | Whole-Body 3D T1-weighted MR Imaging Anatomical Sequences: GE mDixon vs FSE (View) Approaches in Prostate Canc NCT03034070 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Completed | A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metasta NCT02915744 | Nektar Therapeutics | Phase 3 |
| Terminated | CEST- Glucose Enhanced MRI for Metastatic Brain Tumours NCT02796729 | British Columbia Cancer Agency | Phase 2 |
| Unknown | Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s) NCT03002350 | Chang Gung Memorial Hospital | — |
| Completed | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases NCT02721433 | Ottawa Hospital Research Institute | Phase 4 |
| Completed | Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy NCT02711007 | GUO WEI | Phase 2 / Phase 3 |
| Active Not Recruiting | Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy NCT02597348 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors NCT02743637 | SynDevRx, Inc. | Phase 1 |
| Completed | Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver NCT03031444 | Peking University Cancer Hospital & Institute | Phase 2 / Phase 3 |
| Recruiting | Integrative Analysis of CRC Liver Metastasis NCT02917707 | Da Fu | — |
| Unknown | The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC NCT02791607 | Chang Gung Memorial Hospital | — |
| Terminated | Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis NCT02443103 | Kathy Miller | N/A |
| Terminated | Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer NCT03634202 | Institut Cancerologie de l'Ouest | N/A |
| Unknown | A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mF NCT02402972 | Xu jianmin | Phase 3 |
| Unknown | The Clinical Relevance of Immune Cells and CTC in HNSCC Patients NCT02420600 | Chang Gung Memorial Hospital | — |
| Completed | Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses o NCT02317393 | Centre Francois Baclesse | Phase 2 |
| Unknown | Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM NCT02311205 | Asan Medical Center | Phase 2 |
| Unknown | Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients NCT02251353 | Federation of Breast Diseases Societies | — |
| Completed | Radiofrequency Ablation Using Cooled-Wet Electrode NCT02675894 | Seoul National University Hospital | N/A |
| Completed | Salvage Surgery for Patients With Metastatic GIST With Rego NCT04343456 | Chang Gung Memorial Hospital | — |
| Completed | Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®) NCT02675881 | Seoul National University Hospital | N/A |
| Completed | Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment NCT02061085 | MedSIR | Phase 2 |
| Completed | Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma NCT01935700 | Kaohsiung Medical University Chung-Ho Memorial Hospital | Phase 2 |
| Unknown | Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery NCT01798771 | Johann Wolfgang Goethe University Hospital | N/A |
| Completed | Sentinel Lymph Node (SLN) in Colorectal Carcinoma (CRC) With a Near-infrared (NIR)-Dye NCT02122523 | Amsterdam UMC, location VUmc | N/A |
| Completed | Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection. NCT03237195 | University of Mississippi Medical Center | — |
| Terminated | Prognostic Value of CTC in HNSCC Patients NCT01884129 | Chang Gung Memorial Hospital | — |
| Unknown | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis NCT03518502 | Korea University | Phase 4 |
| Completed | Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer NCT01490996 | University of Leicester | Phase 1 / Phase 2 |
| Completed | Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breas NCT01460186 | Centre Leon Berard | N/A |
| Completed | Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies NCT02683538 | Seoul National University Hospital | Phase 2 |
| Withdrawn | A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin NCT01157039 | AHS Cancer Control Alberta | Phase 2 |
| Terminated | ECI301 and Radiation for Advanced or Metastatic Cancer NCT01441115 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Health Related Quality of Life After Surgery and Oncological Treatment of Colorectal Liver Metastases NCT01587976 | Haukeland University Hospital | — |
| Unknown | Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin NCT02087475 | Sixth Affiliated Hospital, Sun Yat-sen University | Phase 3 |
| Completed | Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment NCT01201018 | Oshadi Drug Administration | Phase 1 |
| Completed | Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors NCT01199822 | Eli Lilly and Company | Phase 1 |
| Completed | FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer NCT01206530 | Abramson Cancer Center at Penn Medicine | Phase 1 / Phase 2 |
| Unknown | Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Trans NCT01201096 | University of Jena | — |
| Terminated | Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Mal NCT01190241 | Amsterdam UMC, location VUmc | N/A |
| Withdrawn | Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis NCT01169116 | Barretos Cancer Hospital | Phase 2 |
| Completed | PET-CT and Circulating Tumor Cells in Colorectal Cancer NCT01163305 | Chinese University of Hong Kong | — |
| Unknown | Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer NCT01195298 | South Eastern European Research Oncology Group | Phase 2 |
| Completed | Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizum NCT01405430 | Centre Leon Berard | N/A |
| Terminated | A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Can NCT01000948 | Aarhus University Hospital | Phase 2 |
| Unknown | Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) NCT01069770 | Korean Urological Oncology Society | Phase 2 |
| Unknown | Window Study of ZD4054 in Metastatic Prostate Cancer NCT01168141 | The Christie NHS Foundation Trust | N/A |
| Completed | Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Infiltrations NCT01194843 | Centre Leon Berard | N/A |
| Unknown | Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer NCT00862173 | National Institute of Cancerología | — |
| Terminated | TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention NCT01613482 | Centre Oscar Lambret | Phase 3 |
| Completed | First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible NCT00389155 | Bristol-Myers Squibb | Phase 2 / Phase 3 |
| Completed | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or NCT00371345 | Bristol-Myers Squibb | Phase 2 |
| Completed | A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer NCT00371254 | Bristol-Myers Squibb | Phase 2 |
| Completed | Effect of Samarium on the Relief of Pain Due to Vertebral Metastases NCT00374751 | New York Presbyterian Brooklyn Methodist Hospital | Phase 1 / Phase 2 |
| Unknown | Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer NCT01196455 | Croatian Cooperative Group for Clinical Research in Oncology | Phase 2 |
| Completed | Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients NCT02575859 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 1 / Phase 2 |
| Withdrawn | Hepatic Artery Infusion With Oxaliplatin NCT00244348 | Medical College of Wisconsin | Phase 1 / Phase 2 |
| Completed | EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the NCT00377936 | MediGene | Phase 2 |
| Completed | Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC NCT00313859 | Samsung Medical Center | Phase 2 |
| Unknown | The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal NCT00174096 | National Taiwan University Hospital | — |
| Terminated | Study of GPX-100 in the Treatment of Metastatic Breast Cancer NCT00123877 | Gem Pharmaceuticals | Phase 2 |
| Completed | Extension Program for Bay 43-9006 NCT00657254 | Bayer | Phase 2 |
| Completed | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer NCT00126256 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 |
| Completed | Radiofrequency Ablation of Lung Tumors NCT00180856 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 |
| Completed | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advance NCT00241449 | AstraZeneca | Phase 3 |
| Completed | An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer NCT00051779 | Chugai Pharma USA | Phase 1 |